Hovanesian John A
Harvard Eye Associates, Laguna Hills, CA, USA,
Clinical Faculty, UCLA Jules Stein Eye Institute, Los Angeles, CA, USA,
Clin Ophthalmol. 2018 Nov 12;12:2297-2304. doi: 10.2147/OPTH.S182943. eCollection 2018.
The purpose of this study was to determine the satisfaction levels of patients at least 2 years after cataract surgery implantation with bilateral accommodating or bilateral multifocal intraocular lenses (IOLs) and to determine the relative rate of spectacle independence and adverse symptoms in that same time frame.
Patient questionnaire administered in a single-center private practice at least 2 years after cataract surgery with presbyopia-correcting IOL implantation.
Patients who had undergone uncomplicated cataract surgery with an accommodating or multifocal IOL implant were eligible for inclusion. Patients with visually significant non-IOL-related postoperative morbidity were excluded. Patients with astigmatism or residual refractive error were not excluded. The main outcome measure was patient satisfaction at least 2 years after IOL implantation.
Sixty-eight patients who received accommodating lenses and 49 patients who received multifocal lenses completed the questionnaire. The mean age of all patients was 75.7 years at the time of survey; the mean number of years since cataract surgery was 5.4 years. Overall, there were no significant differences between the two groups or within each group between the different lenses used. About 90% of patients in each group were "very satisfied" or "somewhat satisfied" with their vision at least 2 years after the initial surgery. Conversely, only one in eleven patients found his vision to be worse than expected.
The majority of patients who received either accommodating or multifocal IOLs remain satisfied with their lens of choice more than 5 years after the original surgery. Glare and halos remain more noticeable in patients who received multifocal lenses.
本研究的目的是确定白内障手术植入双侧可调节或双侧多焦点人工晶状体(IOL)至少2年后患者的满意度,并确定同一时间段内不依赖眼镜的相对比例和不良症状。
在一家单中心私人诊所对接受矫正老花眼的IOL植入白内障手术后至少2年的患者进行问卷调查。
接受了可调节或多焦点IOL植入且手术无并发症的患者符合纳入标准。排除术后存在与IOL无关的明显视觉问题的患者。散光或残余屈光不正的患者不排除。主要观察指标是IOL植入至少2年后患者的满意度。
68例接受可调节晶状体的患者和49例接受多焦点晶状体的患者完成了问卷调查。调查时所有患者的平均年龄为75.7岁;白内障手术后的平均年数为5.4年。总体而言,两组之间或每组内使用的不同晶状体之间均无显著差异。每组中约90%的患者在初次手术后至少2年对其视力“非常满意”或“有些满意”。相反,只有十一分之一的患者发现其视力比预期差。
大多数接受可调节或多焦点IOL的患者在初次手术后5年多仍对其选择的晶状体感到满意。接受多焦点晶状体的患者中眩光和光晕仍然更明显。